Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.06M
-
Shares change
-
+23.4K
-
Total reported value, excl. options
-
$2.12M
-
Value change
-
+$46.5K
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$2.00
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q4 2016
11 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q4 2016.
ProPhase Labs, Inc. - COM (PRPH) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.06M shares
.
Largest 10 shareholders include Vantage Investment Partners, LLC (433K shares), Bank of New York Mellon Corp (185K shares), DIMENSIONAL FUND ADVISORS LP (157K shares), RENAISSANCE TECHNOLOGIES LLC (110K shares), PNC FINANCIAL SERVICES GROUP, INC. (60K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (47.4K shares), Commonwealth Equity Services, Inc (17.5K shares), CITADEL ADVISORS LLC (17.2K shares), UBS Group AG (14.8K shares), and NORTHERN TRUST CORP (14K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.